Tuberkulose (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tuberkulose" in German language version.

refsWebsite
Global rank German rank
4th place
7th place
2nd place
3rd place
4,845th place
310th place
1st place
1st place
68th place
29th place
33rd place
2nd place
low place
low place
317th place
14th place
low place
low place
2,569th place
low place
279th place
42nd place
3,043rd place
200th place
2,374th place
1,391st place
low place
682nd place
2,628th place
166th place
195th place
255th place
4,345th place
277th place
low place
1,019th place
7th place
19th place
low place
5,929th place
low place
low place
234th place
203rd place
low place
low place
1,624th place
377th place
low place
low place
2,390th place
169th place
low place
6,112th place
low place
8,138th place
5,704th place
362nd place
low place
low place
low place
low place

IABotmemento.invalid

admin.ch

bag.admin.ch

admin.ch

  • Der Schweizerische Bundesrat: Tierseuchenverordnung (TSV). In: admin.ch. Abgerufen am 16. März 2020 (Schweizer Hochdeutsch, vom 27. Juni 1995 (Stand am 1. Januar 2020)).

blv.admin.ch

  • Tuberkulose beim Tier und beim Menschen. Bundesamt für Lebensmittelsicherheit und Veterinärwesen BLV, 10. März 2010, abgerufen am 16. März 2020 (Schweizer Hochdeutsch): „Die Tuberkulose ist eine auszurottende und somit meldepflichtige Tierseuche. Wer Tiere hält oder betreut, muss Verdachtsfälle dem Bestandestierarzt oder der Bestandestierärztin melden. […]“

aeras.org

aerzteblatt.de

bgbl.de

  • Verordnung über anzeigepflichtige Tierseuchen in der Fassung der Bekanntmachung vom 19. Juli 2011 (BGBl. I S. 1404), geändert durch Artikel 3 der Verordnung vom 3. Mai 2016 (BGBl. I S. 1057)
  • Anlage zu § 1 der Verordnung über meldepflichtige Tierkrankheiten (TKrMeldpflV) in der Fassung der Bekanntmachung vom 11. Februar 2011 (BGBl. I S. 252), zuletzt geändert durch Artikel 381 der Verordnung vom 31. August 2015 (BGBl. I S. 1474)

bka.gv.at

ris.bka.gv.at

bmel.de

cvuas.de

deadurl.invalid

doi.org

  • J. T. Lejeune, P. J. Rajala-Schultz: Food safety: unpasteurized milk: a continued public health threat. In: Clinical Infectious Diseases. Band 48, Nummer 1, Januar 2009, S. 93–100. doi:10.1086/595007. PMID 19053805. (Review).
  • S. Jodra, C. Alvarez: Images in clinical medicine. Pott’s disease of the thoracic spine. In: N Engl J Med. 368(8), 2013, S. 756. doi:10.1056/NEJMicm1207442. PMID 23425168.
  • J. van Ingen, R. E. Aarnoutse u. a.: Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment? In: Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. Band 52, Nr. 9, Mai 2011, S. e194–e199. doi:10.1093/cid/cir184, PMID 21467012 (Review).
  • R. Tasneen, S. Y. Li u. a.: Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis. In: Antimicrobial Agents and Chemotherapy. Band 55, Nr. 12, Dezember 2011, S. 5485–5492. doi:10.1128/AAC.05293-11. PMID 21930883. PMC 3232786 (freier Volltext).
  • M. Lee, J. Lee u. a.: Linezolid for treatment of chronic extensively drug-resistant tuberculosis. In: The New England Journal of Medicine. Band 367, Nummer 16, Oktober 2012, S. 1508–1518. doi:10.1056/NEJMoa1201964. PMID 23075177. PMC 3814175 (freier Volltext).
  • K. Williams, A. Minkowski u. a.: Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis. In: Antimicrobial agents and chemotherapy. Band 56, Nummer 6, Juni 2012, S. 3114–3120. doi:10.1128/AAC.00384-12. PMID 22470112. PMC 3370712 (freier Volltext).
  • L. Amaral, M. Viveiros: Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections. In: International journal of antimicrobial agents. Band 39, Nummer 5, Mai 2012, S. 376–380. doi:10.1016/j.ijantimicag.2012.01.012. PMID 22445204.
  • S. Sharma, A. Singh: Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications. In: Expert opinion on investigational drugs. Band 20, Nummer 12, Dezember 2011, S. 1665–1676. doi:10.1517/13543784.2011.628657. PMID 22014039.
  • T. Schön, J. Idh u. a.: Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis–a randomised trial. In: Tuberculosis. Band 91, Nummer 5, September 2011, S. 370–377. doi:10.1016/j.tube.2011.06.002. PMID 21813328.
  • A. P. Ralph, P. M. Kelly, N. M. Anstey: L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis. In: Trends Microbiol. Band 16, Nr. 7, Juli 2008, S. 336–344, doi:10.1016/j.tim.2008.04.003, PMID 18513971.
  • L. T. Ho-Pham, N. D. Nguyen, T. T. Nguyen u. a.: Association between vitamin D insufficiency and tuberculosis in a Vietnamese population. In: BMC Infect. Dis. Band 10, 2010, S. 306, doi:10.1186/1471-2334-10-306, PMID 20973965, PMC 2978214 (freier Volltext).
  • M. Fabri, S. Stenger u. a.: Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. In: Science Translational Medicine. Band 3, Nummer 104, Oktober 2011, S. 104ra102. doi:10.1126/scitranslmed.3003045. PMID 21998409. PMC 3269210 (freier Volltext).
  • A. K. Coussens, R. J. Wilkinson u. a.: Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. In: Proceedings of the National Academy of Sciences. Band 109, Nummer 38, September 2012, S. 15449–15454. doi:10.1073/pnas.1200072109. PMID 22949664. PMC 3458393 (freier Volltext).
  • S. Subbian, L. Tsenova u. a.: Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs. In: PLOS Pathogens. Band 7, Nummer 9, September 2011, S. e1002262. doi:10.1371/journal.ppat.1002262. PMID 21949656. PMC 3174258 (freier Volltext).
  • K. J. Welsh, S. A. Hwang u. a.: Lactoferrin modulation of mycobacterial cord factor trehalose 6-6'-dimycolate induced granulomatous response. In: Translational research: the journal of laboratory and clinical medicine. Band 156, Nummer 4, Oktober 2010, S. 207–215. doi:10.1016/j.trsl.2010.06.001. PMID 20875896. PMC 2948024 (freier Volltext).
  • Wendy Thanassi, Amy J. Behrman, Randall Reves, Mark Russi, Melanie Swift: Tuberculosis Screening, Testing, and Treatment of US Health Care Personnel: ACOEM and NTCA Joint Task Force on Implementation of the 2019 MMWR Recommendations. In: Journal of Occupational & Environmental Medicine. Band 62, Nr. 7, Juli 2020, S. e355–e369, doi:10.1097/JOM.0000000000001904.
  • P. Andersen, T. M. Doherty: The success and failure of BCG – implications for a novel tuberculosis vaccine. In: Nature reviews. Microbiology. Band 3, Nr. 8, August 2005, S. 656–662. doi:10.1038/nrmicro1211, PMID 16012514. (Review).
  • L. Grode, C. A. Ganoza, C. Brohm, J. Weiner, B. Eisele, S. H. Kaufmann: Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial. In: Vaccine. 2012, doi:10.1016/j.vaccine.2012.12.053, PMID 23290835.
  • M. D. Tameris, M. Hatherill, B. S. Landry, T. J. Scriba, M. A. Snowden, S. Lockhart, J. E. Shea, J. B. McClain, G. D. Hussey, W. A. Hanekom, H. Mahomed, H. McShane: Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. In: The Lancet. doi:10.1016/S0140-6736(13)60177-4.
  • J. C. Lorenzi, A. P. Trombone, C. D. Rocha u. a.: Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis. In: BMC Biotechnol. Band 10, 2010, S. 77, doi:10.1186/1472-6750-10-77, PMID 20961459, PMC 2972232 (freier Volltext).
  • Elisa Nemes, Hennie Geldenhuys, Virginie Rozot, Kathryn T. Rutkowski, Frances Ratangee: Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination. In: New England Journal of Medicine. 11. Juli 2018, doi:10.1056/NEJMoa1714021, PMID 29996082, PMC 5937161 (freier Volltext) – (nejm.org [abgerufen am 21. Dezember 2018]).
  • J. Kappelman, M. C. Alçiçek u. a.: First Homo erectus from Turkey and implications for migrations into temperate Eurasia. In: American journal of physical anthropology. Band 135, Nr. 1, Januar 2008, S. 110–116. doi:10.1002/ajpa.20739, PMID 18067194.
  • I. Hershkovitz, H. D. Donoghue u. a.: Detection and molecular characterization of 9,000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean. In: PloS one. Band 3, Nr. 10, 2008, S. e3426. doi:10.1371/journal.pone.0003426, PMID 18923677. PMC 2565837 (freier Volltext).
  • Bruce M. Rothschild, Larry D. Martin, Galit Lev, Helen Bercovier, Gila Kahila Bar-Gal, Charles Greenblatt, Helen Donoghue, Mark Spigelman, David Brittain: Mycobacterium tuberculosis Complex DNA from an Extinct Bison Dated 17,000 Years before the Present. In: Clin Infect Dis. 33 (3), 2001, S. 305–311. doi:10.1086/321886.
  • Md Abdul Kuddus, Emma S. McBryde, Oyelola A. Adegboye: Delay effect and burden of weather-related tuberculosis cases in Rajshahi province, Bangladesh, 2007–2012. In: Scientific Reports. Band 9, Nr. 1, 3. September 2019, S. 12720, doi:10.1038/s41598-019-49135-8.

europa.eu

ema.europa.eu

idw-online.de

kinder-radiologie.org

mementoweb.org

timetravel.mementoweb.org

mpg.de

nature.com

  • Matthew P. R. Berry, Christine M. Graham, Finlay W. McNab, Zhaohui Xu, Susannah A. A. Bloch u. a.: An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. In: Nature. Vol. 466, 19. August 2010, S. 973–977 (Abstract als html).

nejm.org

news.de

  • Brachten Einwanderer den „Weißen Tod“ zu uns? (Memento des Originals vom 4. Januar 2016 im Internet Archive)  Info: Der Archivlink wurde automatisch eingesetzt und noch nicht geprüft. Bitte prüfe Original- und Archivlink gemäß Anleitung und entferne dann diesen Hinweis.@1@2Vorlage:Webachiv/IABot/www.news.de News.de vom 10. November 2015.

nih.gov

ncbi.nlm.nih.gov

  • J. T. Lejeune, P. J. Rajala-Schultz: Food safety: unpasteurized milk: a continued public health threat. In: Clinical Infectious Diseases. Band 48, Nummer 1, Januar 2009, S. 93–100. doi:10.1086/595007. PMID 19053805. (Review).
  • V. Bordignon, S. Bultrini u. a.: High prevalence of latent tuberculosis infection in autoimmune disorders such as psoriasis and in chronic respiratory diseases, including lung cancer. In: Journal of biological regulators and homeostatic agents. Band 25, Nr. 2, Apr-Jun 2011, S. 213–220. PMID 21880210.
  • A. Koul u. a.: The challenge of new drug discovery for tuberculosis. In: Nature. Band 469, Nr. 7331, 2011, S. 483–490, PMID 21270886.
  • R. Riley: Aerial dissemination of pulmonary tuberculosis. In: Am Rev Tuberc. Band 76, Nr. 5980, 1957, S. 931–941, PMID 13488004.
  • J. L. Flynn, M. M. Goldstein, J. Chan u. a.: Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. In: Immunity. Band 2, Nr. 6, Juni 1995, S. 561–572, PMID 7540941.
  • S. T. Cole u. a.: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. In: Nature. Nr. 393, London 1998, S. 537–554. PMID 9634230.
  • S. Jodra, C. Alvarez: Images in clinical medicine. Pott’s disease of the thoracic spine. In: N Engl J Med. 368(8), 2013, S. 756. doi:10.1056/NEJMicm1207442. PMID 23425168.
  • D. D. Singh, M. Vogel u. a.: TB or not TB? Difficulties in the diagnosis of tuberculosis in HIV-negative immigrants to Germany. In: European journal of medical research. Band 16, Nr. 9, Sept. 2011, S. 381–384. PMID 22024436.
  • H. J. Zar u. a.: Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children, a prospective study. In: The Lancet. Vol. 365, Nr. 9454, London 2005, S. 130–134. PMID 15639294.
  • J. van Ingen, R. E. Aarnoutse u. a.: Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment? In: Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. Band 52, Nr. 9, Mai 2011, S. e194–e199. doi:10.1093/cid/cir184, PMID 21467012 (Review).
  • R. Tasneen, S. Y. Li u. a.: Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis. In: Antimicrobial Agents and Chemotherapy. Band 55, Nr. 12, Dezember 2011, S. 5485–5492. doi:10.1128/AAC.05293-11. PMID 21930883. PMC 3232786 (freier Volltext).
  • M. Lee, J. Lee u. a.: Linezolid for treatment of chronic extensively drug-resistant tuberculosis. In: The New England Journal of Medicine. Band 367, Nummer 16, Oktober 2012, S. 1508–1518. doi:10.1056/NEJMoa1201964. PMID 23075177. PMC 3814175 (freier Volltext).
  • K. Williams, A. Minkowski u. a.: Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis. In: Antimicrobial agents and chemotherapy. Band 56, Nummer 6, Juni 2012, S. 3114–3120. doi:10.1128/AAC.00384-12. PMID 22470112. PMC 3370712 (freier Volltext).
  • S. Yaldiz, S. Gursoy u. a.: Surgery offers high cure rates in multidrug-resistant tuberculosis. In: Ann Thorac Cardiovasc Surg. Band 17, Nr. 2, April 2011, S. 143–147. PMID 21597410.
  • L. Amaral, A. Martins, G. Spengler, A. Hunyadi, J. Molnar: The Mechanism by which the Phenothiazine Thioridazine Contributes to Cure Problematic Drug-Resistant Forms of Pulmonary Tuberculosis: Recent Patents for „New Use“. In: Recent patents on anti-infective drug discovery. [elektronische Veröffentlichung vor dem Druck] Dezember 2013, PMID 24320229.
  • L. Amaral, M. Viveiros: Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections. In: International journal of antimicrobial agents. Band 39, Nummer 5, Mai 2012, S. 376–380. doi:10.1016/j.ijantimicag.2012.01.012. PMID 22445204.
  • S. Sharma, A. Singh: Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications. In: Expert opinion on investigational drugs. Band 20, Nummer 12, Dezember 2011, S. 1665–1676. doi:10.1517/13543784.2011.628657. PMID 22014039.
  • T. Schön, J. Idh u. a.: Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis–a randomised trial. In: Tuberculosis. Band 91, Nummer 5, September 2011, S. 370–377. doi:10.1016/j.tube.2011.06.002. PMID 21813328.
  • A. P. Ralph, P. M. Kelly, N. M. Anstey: L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis. In: Trends Microbiol. Band 16, Nr. 7, Juli 2008, S. 336–344, doi:10.1016/j.tim.2008.04.003, PMID 18513971.
  • L. T. Ho-Pham, N. D. Nguyen, T. T. Nguyen u. a.: Association between vitamin D insufficiency and tuberculosis in a Vietnamese population. In: BMC Infect. Dis. Band 10, 2010, S. 306, doi:10.1186/1471-2334-10-306, PMID 20973965, PMC 2978214 (freier Volltext).
  • M. Fabri, S. Stenger u. a.: Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. In: Science Translational Medicine. Band 3, Nummer 104, Oktober 2011, S. 104ra102. doi:10.1126/scitranslmed.3003045. PMID 21998409. PMC 3269210 (freier Volltext).
  • A. K. Coussens, R. J. Wilkinson u. a.: Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. In: Proceedings of the National Academy of Sciences. Band 109, Nummer 38, September 2012, S. 15449–15454. doi:10.1073/pnas.1200072109. PMID 22949664. PMC 3458393 (freier Volltext).
  • S. Subbian, L. Tsenova u. a.: Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs. In: PLOS Pathogens. Band 7, Nummer 9, September 2011, S. e1002262. doi:10.1371/journal.ppat.1002262. PMID 21949656. PMC 3174258 (freier Volltext).
  • K. J. Welsh, S. A. Hwang u. a.: Lactoferrin modulation of mycobacterial cord factor trehalose 6-6'-dimycolate induced granulomatous response. In: Translational research: the journal of laboratory and clinical medicine. Band 156, Nummer 4, Oktober 2010, S. 207–215. doi:10.1016/j.trsl.2010.06.001. PMID 20875896. PMC 2948024 (freier Volltext).
  • P. Andersen, T. M. Doherty: The success and failure of BCG – implications for a novel tuberculosis vaccine. In: Nature reviews. Microbiology. Band 3, Nr. 8, August 2005, S. 656–662. doi:10.1038/nrmicro1211, PMID 16012514. (Review).
  • BCG: bad news from India. In: Lancet. Band 1, Nummer 8159, Januar 1980, S. 73–74. PMID 6101419.
  • L. Grode, C. A. Ganoza, C. Brohm, J. Weiner, B. Eisele, S. H. Kaufmann: Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial. In: Vaccine. 2012, doi:10.1016/j.vaccine.2012.12.053, PMID 23290835.
  • J. C. Lorenzi, A. P. Trombone, C. D. Rocha u. a.: Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis. In: BMC Biotechnol. Band 10, 2010, S. 77, doi:10.1186/1472-6750-10-77, PMID 20961459, PMC 2972232 (freier Volltext).
  • Elisa Nemes, Hennie Geldenhuys, Virginie Rozot, Kathryn T. Rutkowski, Frances Ratangee: Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination. In: New England Journal of Medicine. 11. Juli 2018, doi:10.1056/NEJMoa1714021, PMID 29996082, PMC 5937161 (freier Volltext) – (nejm.org [abgerufen am 21. Dezember 2018]).
  • T. A. Gous, M. C. Williams: The pathology of tuberculosis caused by Mycobacterium tuberculosis in a herd of semi-free-ranging springbok (Antidorcas marsupialis). In: Onderstepoort J. Vet. Res. Band 76, Nr. 4, Dezember 2009, S. 419–441, PMID 21344792.
  • R. Murphree, J. V. Warkentin u. a.: Elephant-to-human transmission of tuberculosis, 2009. In: Emerging Infectious Diseases. Band 17, Nr. 3, März 2011, S. 366–371. PMID 21392425.
  • J. Kappelman, M. C. Alçiçek u. a.: First Homo erectus from Turkey and implications for migrations into temperate Eurasia. In: American journal of physical anthropology. Band 135, Nr. 1, Januar 2008, S. 110–116. doi:10.1002/ajpa.20739, PMID 18067194.
  • I. Hershkovitz, H. D. Donoghue u. a.: Detection and molecular characterization of 9,000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean. In: PloS one. Band 3, Nr. 10, 2008, S. e3426. doi:10.1371/journal.pone.0003426, PMID 18923677. PMC 2565837 (freier Volltext).

nytimes.com

  • Apoorva Mandavilli: Tuberculosis, Like Covid, Spreads by Breathing, Scientists Report. In: The New York Times. 19. Oktober 2021 (nytimes.com [abgerufen am 20. Oktober 2021]).

pschyrembel.de

redirecter.toolforge.org

rki.de

sozialministerium.at

springerlink.com

stoptb.org

  • Stop TB Partnership. The missed three million. Meldung zum Welttuberkulosetag am 24. März 2014; abgerufen am 8. April 2014.

tb-archiv.de

tstin3d.com

verbrauchergesundheit.gv.at

web.archive.org

who.int

apps.who.int

who.int